New therapies for muscular dystrophy: cautious optimism

被引:49
作者
Cossu, G
Sampaolesi, M
机构
[1] Stem Cell Res Inst, I-20132 Milan, Italy
[2] Univ Roma La Sapienza, Dept Histol & Med Embryol, I-00161 Rome, Italy
[3] Inst Cell Biol & Tissue Engn, I-00128 Rome, Italy
关键词
D O I
10.1016/j.molmed.2004.08.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The quest for a therapy for muscular dystrophy has been the driving force behind the past 40 years of advances in this field. Numerous results, such as the identification of satellite cells and gene mutations that are responsible for most forms of dystrophies, advances in gene transfer and modification technology and, more recently, stem cells, have fueled hopes. However, administering cortical-steroids still remains the only effective treatment available. Several recent advances have uncovered a diversity of possible therapeutic approaches, from pharmacological treatments to gene therapy (exon-skipping and adeno-associated viruses) and cell therapy with different types of newly identified stem cells' Importantly, a combination of these strategies might greatly enhance the possibility of successful therapy.
引用
收藏
页码:516 / 520
页数:5
相关论文
共 47 条
[1]   Myogenic specification of side population cells in skeletal muscle [J].
Asakura, A ;
Seale, P ;
Girgis-Gabardo, A ;
Rudnicki, MA .
JOURNAL OF CELL BIOLOGY, 2002, 159 (01) :123-134
[2]   Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells [J].
Bachrach, E ;
Li, S ;
Perez, AL ;
Schienda, J ;
Liadaki, K ;
Volinski, J ;
Flint, A ;
Chamberlain, J ;
Kunkel, LM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (10) :3581-3586
[3]   Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice [J].
Barton, ER ;
Morris, L ;
Musaro, A ;
Rosenthal, N ;
Sweeney, HL .
JOURNAL OF CELL BIOLOGY, 2002, 157 (01) :137-147
[4]   Function and genetics of dystrophin and dystrophin-related proteins in muscle [J].
Blake, DJ ;
Weir, A ;
Newey, SE ;
Davies, KE .
PHYSIOLOGICAL REVIEWS, 2002, 82 (02) :291-329
[5]   Functional improvement of dystrophic muscle by myostatin blockade [J].
Bogdanovich, S ;
Krag, TOB ;
Barton, ER ;
Morris, LD ;
Whittemore, LA ;
Ahima, RS ;
Khurana, TS .
NATURE, 2002, 420 (6914) :418-421
[6]   Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins [J].
Bonuccelli, G ;
Sotgia, F ;
Schubert, W ;
Park, DS ;
Frank, PG ;
Woodman, SE ;
Insabato, L ;
Cammer, M ;
Minetti, C ;
Lisanti, MP .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (04) :1663-1675
[7]   Muscular dystrophy - Reason for optimism? [J].
Burton, EA ;
Davies, KE .
CELL, 2002, 108 (01) :5-8
[8]   Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates [J].
Camargo, FD ;
Green, R ;
Capetenaki, Y ;
Jackson, KA ;
Goodell, MA .
NATURE MEDICINE, 2003, 9 (12) :1520-1527
[9]   Deflazacort for the treatment of Duchenne Dystrophy: A systematic review [J].
Craig Campbell ;
Pierre Jacob .
BMC Neurology, 3 (1)
[10]   Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential [J].
Cao, BH ;
Zheng, B ;
Jankowski, RJ ;
Kimura, S ;
Ikezawa, M ;
Deasy, B ;
Cummins, J ;
Epperly, M ;
Qu-Petersen, Z ;
Huard, J .
NATURE CELL BIOLOGY, 2003, 5 (07) :640-646